Literature DB >> 35421235

A Structured Approach to Optimizing Animal Model Selection for Human Translation: The Animal Model Quality Assessment.

Joanne Storey1, Thomas Gobbetti2, Alan Olzinski3, Brian R Berridge4.   

Abstract

Animal studies in pharmaceutical drug discovery are common in preclinical research for compound evaluation before progression into human clinical trials. However, high rates of drug development attrition have prompted concerns regarding animal models and their predictive translatability to the clinic. To improve the characterization and evaluation of animal models for their translational relevance, the authors developed a tool to transparently reflect key features of a model that may be considered in both the application of the model but also the likelihood of successful translation of the outcomes to human patients. In this publication, we describe the rationale for the development of the Animal Model Quality Assessment tool, the questions used for the animal model assessment, and a high-level scoring system for the purpose of defining predictive translatability. Finally, we provide an example of a completed Animal Model Quality Assessment for the adoptive T-cell transfer model of colitis as a mouse model to mimic inflammatory bowel disease in humans.
© The Author(s) 2021. Published by Oxford University Press on behalf of the National Academies of Sciences, Engineering, and Medicine. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Animal Model Quality Assessment (AMQA); Animal model; attrition; colitis; drug discovery

Mesh:

Year:  2021        PMID: 35421235      PMCID: PMC9291347          DOI: 10.1093/ilar/ilac004

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020            Impact factor:   1.521


  36 in total

1.  Evolving the Role of Discovery-focused Pathologists and Comparative Scientists in the Pharmaceutical Industry.

Authors:  Sunish Mohanan; Sean Maguire; Jan Klapwijk; Rick Adler; Richard Haworth; Peter Clements
Journal:  Toxicol Pathol       Date:  2019-01-16       Impact factor: 1.902

2.  TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis.

Authors:  Esben Gjerløff Wedebye Schmidt; Hjalte List Larsen; Nanna Ny Kristensen; Steen Seier Poulsen; Anne Marie Lynge Pedersen; Mogens Helweg Claesson; Anders Elm Pedersen
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

3.  Integrating scientific considerations into R&D project valuation.

Authors:  Saco J de Visser; Adam F Cohen; Marcel J H Kenter
Journal:  Nat Biotechnol       Date:  2020-01       Impact factor: 54.908

4.  IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.

Authors:  David Yen; Jeanne Cheung; Heleen Scheerens; Frédérique Poulet; Terrill McClanahan; Brent McKenzie; Melanie A Kleinschek; Alex Owyang; Jeanine Mattson; Wendy Blumenschein; Erin Murphy; Manjiri Sathe; Daniel J Cua; Robert A Kastelein; Donna Rennick
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

5.  A protective function for interleukin 17A in T cell-mediated intestinal inflammation.

Authors:  William O'Connor; Masahito Kamanaka; Carmen J Booth; Terrence Town; Susumu Nakae; Yoichiro Iwakura; Jay K Kolls; Richard A Flavell
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

Review 6.  Current concepts of Harm-Benefit Analysis of Animal Experiments - Report from the AALAS-FELASA Working Group on Harm-Benefit Analysis - Part 1.

Authors:  Aurora Brønstad; Christian E Newcomer; Thierry Decelle; Jeffrey I Everitt; Javier Guillen; Kathy Laber
Journal:  Lab Anim       Date:  2016-06       Impact factor: 2.471

7.  Pharmacological Evaluation of the SCID T Cell Transfer Model of Colitis: As a Model of Crohn's Disease.

Authors:  Thomas Lindebo Holm; Steen Seier Poulsen; Helle Markholst; Stine Reedtz-Runge
Journal:  Int J Inflam       Date:  2012-02-19

8.  The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research.

Authors:  Nathalie Percie du Sert; Viki Hurst; Amrita Ahluwalia; Sabina Alam; Marc T Avey; Monya Baker; William J Browne; Alejandra Clark; Innes C Cuthill; Ulrich Dirnagl; Michael Emerson; Paul Garner; Stephen T Holgate; David W Howells; Natasha A Karp; Stanley E Lazic; Katie Lidster; Catriona J MacCallum; Malcolm Macleod; Esther J Pearl; Ole H Petersen; Frances Rawle; Penny Reynolds; Kieron Rooney; Emily S Sena; Shai D Silberberg; Thomas Steckler; Hanno Würbel
Journal:  PLoS Biol       Date:  2020-07-14       Impact factor: 8.029

Review 9.  Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases.

Authors:  Jacob M Favret; Nadav I Weinstock; M Laura Feltri; Daesung Shin
Journal:  Front Mol Biosci       Date:  2020-04-15

10.  SYRCLE's risk of bias tool for animal studies.

Authors:  Carlijn R Hooijmans; Maroeska M Rovers; Rob B M de Vries; Marlies Leenaars; Merel Ritskes-Hoitinga; Miranda W Langendam
Journal:  BMC Med Res Methodol       Date:  2014-03-26       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.